Abingdon Health PLC

ABDX

Company Profile

  • Business description

    Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.

  • Contact

    York Biotech Campus
    Sand Hutton
    YorkYO41 1LZ
    GBR

    T: +44 1904406050

    E: [email protected]

    https://www.abingdonhealth.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2027

    Employees

    129

Stocks News & Analysis

stocks

Pure-play data center share raises capital to fund AI demand

Funding the next wave of data center growth.
stocks

Chart of the Week: BHP’s growth story faces a reality check

China’s slowing economy could weigh on BHP’s future growth.
stocks

3 best ASX growth stocks to buy for the long term

Here’s three high-quality growth companies with wide moats.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,978.8034.20-0.38%
CAC 408,338.8139.05-0.47%
DAX 4024,830.9884.51-0.34%
Dow JONES (US)52,146.42406.55-0.77%
FTSE 10010,600.3728.130.27%
HKSE24,562.24446.36-1.78%
NASDAQ25,520.24361.70-1.40%
Nikkei 22564,141.122,694.42-4.03%
NZX 50 Index13,694.6879.900.59%
S&P 5007,457.6976.08-1.01%
S&P/ASX 2008,796.7020.10-0.23%
SSE Composite Index3,764.15118.26-3.05%

Market Movers